Related Experiment Video
Updated: Jun 18, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal
Rebeca Lorca1, Andrea Aparicio2, Luis Gutiérrez2
1Área del Corazón, Hospital Universitario Central Asturias, 33011 Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, 33011 Oviedo, Spain; Departamento de Morfología y Biología Celular, Universidad de Oviedo, 33003 Oviedo, Spain; Unidad de Cardiopatías Familiares, Área del Corazón y Departamento de Genética Molecular, Hospital Universitario Central Asturias, 33011 Oviedo, Spain; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORs), 28029 Madrid, Spain.
Insights
This study found no association between PCSK9 gene variations and cardiovascular disease risk factors or severity in young myocardial infarction patients. PCSK9 genotypes did not differ between patients and controls, suggesting no link to premature STEMI.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- The association between PCSK9 gene variations and cardiovascular disease (CVD) remains controversial.
- This study investigates three specific PCSK9 polymorphisms in young patients experiencing ST-segment elevation myocardial infarction (STEMI).
Purpose of the Study:
- To evaluate the association between three reported PCSK9 gene polymorphisms and cardiovascular disease in a cohort of young STEMI patients.
- To determine if PCSK9 genotypes correlate with clinical variables or the extent of coronary artery disease (CAD) in this population.
Main Methods:
- A retrospective study included 216 patients with premature STEMI (2018-2023) and 200 controls.
- Genotyping was performed for three PCSK9 polymorphisms (rs12117661, rs2483205, rs505151) in 207 patients and the control group.
Main Results:
- No significant differences in genotype frequencies were observed between STEMI patients and controls, with distributions adhering to Hardy-Weinberg equilibrium.
- Among STEMI patients, PCSK9 genotypes showed no association with clinical variables such as age, gender, cardiovascular risk factors, cholesterol levels, family history of premature CAD, or the number of affected coronary arteries.
Conclusions:
- The study found no association between the investigated PCSK9 genotypes (rs12117661, rs2483205, rs505151) and cardiovascular risk factors or the extent of CAD in patients with premature STEMI.
- Genotype distribution did not differ between the patient and control groups, indicating no significant genetic link through these specific polymorphisms in this cohort.
Introduction:
Information about PCSK9 gene variations and its association with cardiovascular (CV) disease is controversial. We aimed to evaluate 3 reported polymorphisms in PSCK9 in a cohort of young patients with myocardial infarction with ST segment elevation (STEMI).
Methods:
Retrospective study of consecutive patients with premature STEMI (2018-2023). 216 patients with STEMI due atherothrombotic coronary artery disease (CAD), confirmed by coronary angiogram, were included. We genotyped 3 polymorphisms in PCSK9 (rs12117661, rs2483205, rs505151) in 207 patients (DNA unavailable in 9) and a control group (N = 200).
Results:
Mean age 49.4 ± 6,6 years (82.4% men). Genotypes frequencies distribution in patient's and control's cohorts did not deviate from the expected by Hardy-Weinberg equilibrium and there were no significant differences between patients and controls. Among patients, we did not find any association between PSCK9 genotypes and clinical variables (gender, age, CV risk factors, cholesterol levels, family history of premature CAD or number of coronary arteries affected).
Conclusion:
We did not find any association between PSCK9 genotypes (RS12117661, RS2483205 and RS505151) and any CV risk factors or the extent of CAD in a cohort of patients with premature STEMI. There were not differences in the genotype distribution between patients and controls.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Incomplete Dominance
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...